Simpson, 1976, Prenatal diagnosis of genetic disease in Canada: report of a collaborative study, Can Med Assoc J, 115, 739
Golbus, 1979, Prenatal genetic diagnosis in 3000 amniocenteses, N Engl J Med, 300, 157, 10.1056/NEJM197901253000402
Crandall, 1980, Follow-up of 2000 second-trimester amniocenteses, Obstet Gynecol, 56, 625
Sant-Cassia, 1984, Midtrimester amniocentesis: is it safe?, BJOG, 91, 736, 10.1111/j.1471-0528.1984.tb04842.x
Tongsong, 1998, Amniocentesis-related fetal loss: a cohort study, Obstet Gynecol, 92, 64, 10.1016/S0029-7844(98)00125-2
2001, Clinical management guidelines for obstetrician- gynecologists, Obstet Gynecol, 97, 1
1976, Midtrimester amniocentesis for prenatal diagnosis, JAMA, 236, 1471, 10.1001/jama.1976.03270140023016
Brumfield, 1996, Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks’ gestation, Obstet Gynecol, 88, 114, 10.1016/0029-7844(96)00082-8
Antsaklis, 2000, Genetic amniocentesis in women 20-34 years old: associated risks, Prenat Diagn, 20, 247, 10.1002/(SICI)1097-0223(200003)20:3<247::AID-PD794>3.0.CO;2-O
Cruikshank, 1983, Midtrimester amniocentesis, Am J Obstet Gynecol, 146, 204, 10.1016/0002-9378(83)91055-4
Tabor, 1986, Randomised controlled trial of genetic amniocentesis in 4606 low-risk women, Lancet, 1, 1287, 10.1016/S0140-6736(86)91218-3
Caughey, 2006, Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss, Obstet Gynecol, 108, 612, 10.1097/01.AOG.0000232512.46869.fc
Papantoniou, 2001, Risk factors predisposing to fetal loss following a second trimester amniocentesis, BJOG, 108, 1053
Liu, 1987, A prospective study of spontaneous miscarriage in ultrasonically normal pregnancies and relevance to chorion villus sampling, Prenat Diagn, 7, 223, 10.1002/pd.1970070310
Hoesli, 2001, Spontaneous fetal loss rates in a non-selected population, Am J Med Genet, 100, 106, 10.1002/1096-8628(20010422)100:2<106::AID-AJMG1238>3.0.CO;2-L
Sebire, 2001, Choriodecidual inflammatory syndrome (CoDIS) is the leading, and under recognised, cause of early preterm delivery and second trimester miscarriage, Med Hypotheses, 56, 497, 10.1054/mehy.2000.1204
Spong, 1997, Angiogenin: a marker for preterm delivery in midtrimester amniotic fluid, Am J Obstet Gynecol, 176, 415, 10.1016/S0002-9378(97)70508-8
Chaiworapongsa, 2002, Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss, J Matern Fetal Neonatal Med, 12, 159, 10.1080/jmf.12.3.159.164
Wenstrom, 1996, Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss, Am J Obstet Gynecol, 175, 830, 10.1016/S0002-9378(96)80007-X
Romero, 1995, Two thirds of spontaneous abortion/fetal deaths after genetic midtrimester amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity, Am J Obstet Gynecol, 172, 261, 10.1016/0002-9378(95)90715-7
Savva, 2006, Maternal age-specific fetal loss rates in Down syndrome pregnancies, Prenat Diagn, 26, 499, 10.1002/pd.1443
Won, 2005, The timing of demise in fetuses with trisomy 21 and trisomy 18, Prenat Diagn, 25, 608, 10.1002/pd.1243
Eddleman, 2003, Pregnancy loss rates after midtrimester amniocentesis: the FASTER trial, Am J Obstet Gynecol, 189, S111, 10.1016/j.ajog.2003.10.174
Krause, 2001, Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome, Obstet Gynecol, 97, 277, 10.1016/S0029-7844(00)01109-1
Jacobson, 1967, Intrauterine diagnosis and management of genetic defects, Am J Obstet Gynecol, 99, 796, 10.1016/0002-9378(67)90395-X
2001, Clinical management guidelines for obstetrician-gynecologists, Obstet Gynecol, 97, 1
1995, Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling, Morb Mortal Wkly Rep, 44, 1
Romero, 1985, Sonographically monitored amniocentesis to decrease intraoperative complications, Obstet Gynecol, 65, 426
Seeds, 2004, Diagnostic mid trimester amniocentesis: how safe?, Am J Obstet Gynecol, 191, 608, 10.1016/j.ajog.2004.05.078